Skip to main content
logo
Ono Pharmaceutical Co., Ltd. (TYO:4528)
Japan flag Japan · Delayed Price · Currency is JPY
2,415.00
-26.50 (-1.09%)
May 19, 2026, 10:04 AM JST

Ono Pharmaceutical Revenue

In the fiscal year ending March 31, 2026, Ono Pharmaceutical had annual revenue of 515.79B JPY with 5.94% growth. Ono Pharmaceutical had revenue of 118.75B in the quarter ending March 31, 2026, with 5.73% growth.

Revenue
515.79B
Revenue Growth
+5.94%
P/S Ratio
2.22
Revenue / Employee
120.31M
Employees
4,287
Market Cap
1.15T

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 2026515.79B28.91B5.94%
Mar 31, 2025486.87B-15.80B-3.14%
Mar 31, 2024502.67B55.49B12.41%
Mar 31, 2023447.19B85.83B23.75%
Mar 31, 2022361.36B52.08B16.84%
Mar 31, 2021 Pro Pro Pro
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Otsuka Holdings2.52T
Astellas Pharma2.14T
Daiichi Sankyo Company2.12T
Chugai Pharmaceutical1.29T
Kyowa Kirin510.57B
Santen Pharmaceutical291.62B
JCR Pharmaceuticals40.32B
Perseus Proteomics140.41M
Revenue Rankings

Ono Pharmaceutical News

More News